1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Covance Inc. - Strategy and SWOT Report

Covance Inc. - Strategy and SWOT Report

  • November 2015
  • -
  • MarketLine
  • -
  • 22 pages

Introduction

Covance Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Features:

- Detailed information on Covance Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Covance Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Covance Inc. including a breakdown and examination of key business segments

- Intelligence on Covance Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Covance Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Covance Inc. (Covance or “the company”) is a global contract research organization and drug development services company. The company provides product development services to pharmaceutical and biotech companies. It also provides laboratory testing services to chemical, agrochemical and food industries. Covance primarily operates in the US where it is headquartered in Princeton, New Jersey and employed 12,861 people as on December 31, 2014. The company recorded revenues of $2,699.6 million during the financial year ended December 2014 (FY2014), an increase of 4% over FY2013. The operating profit of the company was $234.8 million in FY2014, an increase of 8.1% over FY2013. The net profit of the company was $185.8 million in FY2014, an increase of 3.7% over FY2013.

Reasons to Purchase:

- Gain understanding of Covance Inc. and the factors that influence its strategies

- Track strategic initiatives of the company and latest corporate news and actions

- Assess Covance Inc. as a prospective partner, vendor or supplier

- Support sales activities by understanding your customers' businesses better

- Stay up to date on Covance Inc.’s business structure, strategy and prospects

Table Of Contents

Covance Inc. - Strategy and SWOT Report
Company Overview
Business Description
History
Key Employees and Biographies
Company View
Locations and Subsidiaries
SWOT Analysis
Revenue Analysis
Key Competitors
Major Products and Services

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Translational Drug Development LLC (TD2) is a drug development organization that specializes in providing oncology treatments to cancer patients. The organization provides services such as regulatory ...

International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary International Drug Development Institute (IDDI) provides clinical data collection, analysis, trial design and trial reporting. It offers services such as biostatistical services and eClinical services, ...

TransGenic Inc. (2342) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TransGenic Inc. (2342) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary TransGenic Inc. (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The products and services ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.